Template:ADA guidelines: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''A..." |
Tarek Nafee (talk | contribs) No edit summary |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
'''ADA | '''2016 ADA Guideline Recommendations ''' | ||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="BrilliantLavendar" | ||
! | |||
'''Types of Diabetes Mellitus''' | |||
|- | |||
! | |||
|- bgcolor="Lavender" | |||
! | ! | ||
[[Diabetes mellitus|Main Diabetes Page]] | [[Diabetes mellitus|Main Diabetes Page]] | ||
| Line 13: | Line 19: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Lavender" | ||
! | ! | ||
[[Diabetes mellitus type 1|Diabetes type I]] | [[Diabetes mellitus type 1|Diabetes type I]] | ||
| Line 19: | Line 25: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Lavender" | ||
! | ! | ||
[[Diabetes mellitus type 2|Diabetes type II]] | [[Diabetes mellitus type 2|Diabetes type II]] | ||
| Line 25: | Line 31: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Lavender" | ||
! | ! | ||
[[Gestational diabetes|Gestational Diabetes Mellitus]] | [[Gestational diabetes|Gestational Diabetes Mellitus]] | ||
| Line 31: | Line 37: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="LightCoral" | ||
! | ! | ||
'''ADA Standard of Medical Care | '''2016 ADA Standard of Medical Care Guideline Recommendations''' | ||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Strategies for Improving Care]] | [[Strategies for Improving Care]] | ||
| Line 43: | Line 49: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Classification and Diagnosis of Diabetes]] | [[Classification and Diagnosis of Diabetes]] | ||
| Line 49: | Line 55: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
'''Foundations of Care and Comprehensive Medical Evaluation''' | '''[[Foundations of Care and Comprehensive Medical Evaluation]]''' | ||
:[[ | :[[Diabetes Self-Management, Education, and Support]] | ||
:[[ | :[[Nutritional Therapy in Diabetes|Nutritional Therapy]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Prevention or Delay of Type II Diabetes]] | [[Prevention or Delay of Type II Diabetes]] | ||
| Line 63: | Line 69: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Glycemic Targets]] | [[Glycemic Targets in Diabetes|Glycemic Targets]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Obesity Management for Treatment of Type II Diabetes]] | [[Obesity Management for Treatment of Type II Diabetes]] | ||
| Line 75: | Line 81: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Approaches to Glycemic Treatment]] | [[Approaches to Glycemic Treatment in Diabetes|Approaches to Glycemic Treatment]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
'''Cardiovascular Disease and Risk Management''' | '''Cardiovascular Disease and Risk Management''' | ||
:[[Hypertension and Blood Pressure Control in Diabetics]] | :[[Hypertension and Blood Pressure Control in Diabetics|Hypertension and Blood Pressure Control]] | ||
:[[Lipid Management in Diabetics]] | :[[Lipid Management in Diabetics|Lipid Management]] | ||
:[[Antiplatelet agents in Diabetics]] | :[[Antiplatelet agents in Diabetics|Antiplatelet Agents]] | ||
:[[Coronary heart disease in Diabetics]] | :[[Coronary heart disease in Diabetics|Coronary Heart Disease]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Microvascular Complications and Foot Care]] | [[Microvascular Complications and Foot Care]] | ||
:[[Diabetic Kidney Disease Recommendations]] | :[[Diabetic Kidney Disease Recommendations|Diabetic Kidney Disease]] | ||
:[[Diabetic Retinopathy Recommendations]] | :[[Diabetic Retinopathy Recommendations|Diabetic Retinopathy]] | ||
:[[Diabetic Neuropathy Recommendations]] | :[[Diabetic Neuropathy Recommendations|Diabetic Neuropathy]] | ||
:[[Diabetic Foot care Recommendations]] | :[[Diabetic Foot care Recommendations|Diabetic Footcare]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Older Adults with Diabetes]] | [[Older Adults with Diabetes]] | ||
| Line 107: | Line 113: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Children and Adolescents with Diabetes]] | [[Children and Adolescents with Diabetes]] | ||
| Line 115: | Line 121: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Management of Diabetes in Pregnancy]] | [[Management of Diabetes in Pregnancy]] | ||
| Line 121: | Line 127: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Diabetes Care in the Hospital Setting]] | [[Diabetes Care in the Hospital Setting]] | ||
|- | |- | ||
! | ! | ||
|} | |} | ||
Latest revision as of 16:54, 7 December 2016
|
2016 ADA Guideline Recommendations |
|
Types of Diabetes Mellitus |
|---|
|
2016 ADA Standard of Medical Care Guideline Recommendations |
|
Cardiovascular Disease and Risk Management |